Total Payments
$6,641
2024 Payments
$443.31
Companies
40
Transactions
491
Payment Breakdown by Category
Food & Beverage$6,499 (97.9%)
Education$141.18 (2.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,499 | 482 | 97.9% |
| Education | $141.18 | 9 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,117 | 57 | $0 (2024) |
| Novo Nordisk Inc | $894.71 | 77 | $0 (2024) |
| ABBVIE INC. | $484.05 | 33 | $0 (2024) |
| PFIZER INC. | $412.03 | 45 | $0 (2023) |
| Lilly USA, LLC | $393.67 | 34 | $0 (2024) |
| Merck Sharp & Dohme LLC | $370.05 | 38 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $368.39 | 30 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $291.83 | 19 | $0 (2022) |
| Astellas Pharma US Inc | $280.14 | 13 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $265.67 | 24 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $443.31 | 26 | AstraZeneca Pharmaceuticals LP ($188.23) |
| 2023 | $786.53 | 44 | AstraZeneca Pharmaceuticals LP ($190.67) |
| 2022 | $819.65 | 56 | ABBVIE INC. ($171.42) |
| 2021 | $279.47 | 19 | AbbVie Inc. ($81.49) |
| 2020 | $51.29 | 3 | SANOFI-AVENTIS U.S. LLC ($20.64) |
| 2019 | $1,192 | 80 | Novo Nordisk Inc ($251.54) |
| 2018 | $1,242 | 101 | Novo Nordisk Inc ($191.60) |
| 2017 | $1,826 | 162 | Novo Nordisk Inc ($286.93) |
All Payment Transactions
491 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Diabetes Care | ||||||
| 11/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Diabetes Care | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Diabetes Care | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: DIABETES | ||||||
| 08/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardio-renal | ||||||
| 07/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: DIABETES | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Respiratory | ||||||
| 06/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Diabetes | ||||||
| 05/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Diabetes | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Respiratory | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Respiratory | ||||||
| 04/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Respiratory | ||||||
| 03/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Respiratory | ||||||
| 02/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Robert Lindsay, DO
Dr. Robert Lindsay, DO is a Occupational Medicine healthcare provider based in Orrville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144383043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Lindsay, DO has received a total of $6,641 in payments from pharmaceutical and medical device companies, with $443.31 received in 2024. These payments were reported across 491 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($6,499).
Ad
Practice Information
- Specialty Occupational Medicine
- Other Specialties Family Medicine
- Location Orrville, OH
- Active Since 12/19/2006
- Last Updated 12/09/2013
- Taxonomy Code 2083X0100X
- Entity Type Individual
- NPI Number 1144383043
Products in Payments
- FARXIGA (Drug) $454.04
- JARDIANCE (Drug) $394.81
- Victoza (Drug) $277.21
- BREZTRI (Drug) $263.73
- JANUVIA (Drug) $256.93
- VRAYLAR (Drug) $250.84
- Ozempic (Drug) $237.42
- XARELTO (Drug) $215.32
- SYMBICORT (Drug) $172.26
- AIRSUPRA (Drug) $169.40
- XIFAXAN (Drug) $168.29
- ELIQUIS (Drug) $166.80
- CHANTIX (Drug) $162.00
- UBRELVY (Drug) $157.74
- Myrbetriq (Drug) $115.04
- MOUNJARO (Drug) $106.80
- SOLIQUA (Drug) $102.75
- Tresiba (Drug) $102.44
- Saxenda (Drug) $101.70
- ANORO (Drug) $95.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.